BFRI
BFRI
NASDAQ · Pharmaceuticals

Biofrontera Inc

$0.83
+0.02 (+2.50%)
As of Nov 7, 10:59 PM ET ·
Financial Highlights (FY 2026)
Revenue
60.89M
Net Income
-15,384,074
Gross Margin
73.7%
Profit Margin
-25.3%
Rev Growth
+13.3%
D/E Ratio
0.44
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 73.7% 73.7% 59.5% 59.5%
Operating Margin -27.2% -24.5% 39.9% 36.7%
Profit Margin -25.3% -24.0% 28.1% 33.2%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 60.89M 53.74M 1.67M 1.59M
Gross Profit 44.89M 39.61M 993.6K 946.5K
Operating Income -16,569,441 -13,160,795 666.0K 584.8K
Net Income -15,384,074 -12,219,280 470.0K 528.6K
Gross Margin 73.7% 73.7% 59.5% 59.5%
Operating Margin -27.2% -24.5% 39.9% 36.7%
Profit Margin -25.3% -24.0% 28.1% 33.2%
Rev Growth +13.3% +13.3% +24.3% +24.6%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 1.87M 1.87M 868.4K 1.11M
Total Equity 4.28M 4.28M 5.54M 6.06M
D/E Ratio 0.44 0.44 0.16 0.18
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -16,423,739 -13,769,792 856.8K 789.7K
Free Cash Flow — — 585.2K 384.5K